Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SA-504

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
The effect of the antispasmodic agent, SA-504 subtle granules, was studied. Ninety mg per day of timepidium bromide subtle… Expand
1977
1977
The colored substances excreted in bile or urine have bee investigated after adminstration of a high dose of SQ-504 to rats. A… Expand
1976
1976
Relationship between pharmacological activities and blood levels of a new anticholinergic agent (SA-504), as well as excretion… Expand
1973
1973
Effects of 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504) on the motility of gastrointestinal… Expand
1973
1973
An influence of a new antispasmodica, SA-504, 1, 1-Dimethy1-5-methoxy-3-(dithiene-2-ylmethylene)-piperidinium bromide upon the… Expand
1973
1973
An influence of a new antispasmodica, SA-504, 1, 1-Dimethy1-5-methoxy-3-(dithiene-2-ylmethylene)-piperidinium bromide upon the… Expand
1972
1972
Abstract In the course of screening anticholinergic agents, tipepidine hibenzoate (Asverin®), a piperidine derivative with a… Expand